Janux Therapeutics, Inc.
JANX
Jodie situation report
Janux Therapeutics, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 17 directly disclosed connections are confirming.
- JANX's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if JANX's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind JANX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
MRKMerck & Company, Inc.competitorMay 7, 2026 ▾
“Many other companies have commercialized and/or are developing immuno-oncology or autoimmune treatments including large pharmaceutical and biotechnology companies, such as AbbVie, Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Gilead, GSK, Johnson & Johnso…”
BMYBristol-Myers Squibb CompanypartnerMay 7, 2026 ▾
“In addition to our wholly-owned pipeline programs, we have strategic research collaborations with Merck Sharp & Dohme Corp.”
Depended on by
XNCRXencor, Inc.competitorFeb 25, 2026 ▾
“Other companies conducting clinical trials of CD3- or CD28-based bispecific antibodies directed to solid tumor antigens include Amgen, Astellas, Context Therapeutics Inc., CytomX Therapeutics, Inc., Genmab A/S, Immunocore Holdings plc, Janux Therapeutics, Inc…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 18 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
JANX is currently a Follower in the organic co-movement group Biotechnology and Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for JANX; it is not active in the latest market snapshot.